The relationship between the RPR ratio and hospital mortality in a Cox regression model
| Variable | Non-adjusted model | P value | Adjust model I | P value | Adjust model II | P value |
| HR (95% CI) | HR (95% CI) | HR (95% CI) | ||||
| RPR ratio | 1.92 (1.44 to 2.58) | <0.0001 | 1.91 (1.42 to 2.56) | <0.0001 | 1.63 (1.03 to 2.57) | 0.0357 |
| RPR ratio quartile | ||||||
| Q1 | Ref | Ref | Ref | |||
| Q2 | 0.88 (0.73 to 1.06) | 0.1906 | 0.89 (0.74 to 1.07) | 0.2227 | 0.82 (0.68 to 1.01) | 0.0565 |
| Q3 | 0.94 (0.78 to 1.12) | 0.4705 | 0.92 (0.77 to 1.10) | 0.3650 | 0.92 (0.76 to 1.12) | 0.4047 |
| Q4 | 1.30 (1.10 to 1.53) | 0.0016 | 1.30 (1.10 to 1.53) | 0.0020 | 1.20 (1.01 to 1.43) | 0.0473 |
| P for trend | 0.0009 | 0.0013 | 0.0177 |
RPR ratio: cell distribution width to platelet ratio; Non-adjusted model adjust for: none; Adjust I model adjust for: age, weight, ethnicity; Adjust II model adjust for: age, weight, ethnicity, hyperlipdemia, Charlson Comorbidity Index; HAS-BLED, a recently developed and validated scoring system to assess bleeding risk in patients with atrial fibrillation (AF) who are receiving anticoagulant therapy, creatinine.
APS-III, Acute Physiology Score-III; CABG, coronary artery bypass grafting, urine output; PTT, partial thromboplastin time, troponint, warfarin, betablockers, vasopressin; SAPS-II, Simplified Acute Physiology Score-II, respiratory rate, temperature.